WHO Group 5 Drugs and Difficult Multidrug-Resistant Tuberculosis: a Systematic Review with Cohort Analysis and Meta-Analysis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
WHO Group 5 Drugs and Difficult Multidrug-Resistant Tuberculosis: a Systematic Review with Cohort Analysis and Meta-Analysis
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 57, Issue 9, Pages 4097-4104
Publisher
American Society for Microbiology
Online
2013-06-18
DOI
10.1128/aac.00120-13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Can Intermittent Dosing Optimize Prolonged Linezolid Treatment of Difficult Multidrug-Resistant Tuberculosis?
- (2013) Kwok-Chiu Chang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis
- (2012) Giovanni Sotgiu et al. EUROPEAN RESPIRATORY JOURNAL
- On linezolid efficacy and tolerability
- (2012) S. De Lorenzo et al. EUROPEAN RESPIRATORY JOURNAL
- Efficacy and safety of meropenem–clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB
- (2012) Saverio De Lorenzo et al. EUROPEAN RESPIRATORY JOURNAL
- Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections
- (2012) Leonard Amaral et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Linezolid for the treatment of complicated drug-resistant tuberculosis: a systematic review and meta-analysis [Review article]
- (2012) H. Cox et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis [Case study]
- (2012) M. C. Payen et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Linezolid in the treatment of MDR-TB: a retrospective clinical study
- (2012) H-B. Xu et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children
- (2012) P. C. Rose et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis
- (2012) Teesta Dey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients
- (2012) W.-J. Koh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Role of clofazimine in the treatment of multidrug-resistant tuberculosis: a retrospective observational cohort assessment
- (2012) Hong-Bin Xu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis
- (2012) Myungsun Lee et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients
- (2012) Shama D. Ahuja et al. PLOS MEDICINE
- Clofazimine in the treatment of multidrug-resistant tuberculosis
- (2011) H.-B. Xu et al. CLINICAL MICROBIOLOGY AND INFECTION
- Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis
- (2011) M. Villar et al. EUROPEAN RESPIRATORY JOURNAL
- Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine
- (2011) E. Abbate et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Linezolid in the treatment of multidrug-resistant/extensively drug-resistant tuberculosis in paediatric patients: Experience of a paediatric infectious diseases unit
- (2011) Paula Kjöllerström et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
- (2010) Armand Van Deun et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06
- (2010) H. A. Anger et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- HIV Coinfection in Multidrug- and Extensively Drug-Resistant Tuberculosis Results in High Early Mortality
- (2009) Neel R. Gandhi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Linezolid in the Treatment of Multidrug‐Resistant Tuberculosis
- (2009) G. F. Schecter et al. CLINICAL INFECTIOUS DISEASES
- A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis
- (2009) G. B. Migliori et al. EUROPEAN RESPIRATORY JOURNAL
- Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis
- (2009) Evan W Orenstein et al. LANCET INFECTIOUS DISEASES
- In Vitro Activities of Linezolid against Clinical Isolates of Mycobacterium tuberculosis Complex Isolated in Taiwan over 10 Years
- (2008) T.-S. Huang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis
- (2008) Hae-Seong Nam et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Extensively Drug-Resistant Tuberculosis in the United States, 1993-2007
- (2008) N. Sarita Shah JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study
- (2008) Salmaan Keshavjee et al. LANCET
- Comprehensive Treatment of Extensively Drug-Resistant Tuberculosis
- (2008) Carole D. Mitnick et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started